Why the study?
Does esmolol control blood pressure during electroconvulsive therapy in a patient with an intracranial aneurysm?
Does esmolol control blood pressure during electroconvulsive therapy in a patient with an intracranial aneurysm?
Esmolol may be utilized to manage transient hemodynamic alterations during ECT in patients at high risk for intracranial aneurysm rupture.
Answers are grounded in this paper and cite their sources.
Does not support changing ECT practice in aneurysmal disease; case report leaves open esmolol's role and safety.
Electroconvulsive therapy (ECT) is a commonly used treatment modality for patients with major affective disorders that are unresponsive to pharmacological therapy. While ECT has been shown to be a very safe treatment, it is associated with transient hemodynamic alterations, including hypertension, which are associated with an increased risk of rupture of an intracranial aneurysm. We describe our use of the ultrashort acting beta-blocker, esmolol, for blood-pressure control in a woman with known cerebral aneurysmal disease who required ECT for treatment of recurrent major depression.
No takes yet. Share an insight, caveat, or question.
Kolano et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: